Maggie Nye, Isabelle Johannessen

BioticsAI CEO Robhy Bustami discussed the company's approach to navigating FDA approval, fundraising, and team motivation in a highly regulated healthcare space. The conversation, part of TechCrunch's Build Mode series, focused on how the startup has managed regulatory complexity while maintaining momentum. Bustami shared insights on cutting through red tape and keeping the organization aligned during the lengthy approval process that characterizes healthcare AI ventures.